| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |